Healthcare -
Biotechnology - NASDAQ - US
$ 18.13
6.27 %
$ 1.44 B
Market Cap
-4.2
P/E
VRDN - TOTAL LIABILITIES
Total Liabilities VRDN - Viridian Therapeutics, Inc.
48.4 M
LAST VALUE
73.97%
2 YEAR CAGR
26.74%
5 YEAR CAGR
40.23%
10 YEAR CAGR